Arab Press

بالشعب و للشعب
Friday, Mar 29, 2024

Rare Blood Clot Risk Higher From Coronavirus Than Vaccine, Says UK Study

Rare Blood Clot Risk Higher From Coronavirus Than Vaccine, Says UK Study

The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.
The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.

The research found that the rare blood clotting known as Cerebral Venous Thrombosis (CVT) is more common after COVID-19 than in any of the comparison groups, with 30 per cent of these cases occurring in the under 30s.

Compared to the current COVID-19 vaccines being administered, this risk is between 8-10 times higher, and compared to the baseline, approximately 100 times higher.

The study follows reports of possible links between the Oxford/AstraZeneca vaccine and rare cases of CVT, which are undergoing deeper investigations by the medicines regulators even as the jabs have been ruled as safe and effective.

"There are concerns about possible associations between vaccines and CVT, causing governments and regulators to restrict the use of certain vaccines. Yet, one key question remained unknown: 'What is the risk of CVT following a diagnosis of COVID-19?''," said Paul Harrison, one of study authors as Professor of Psychiatry and Head of the Translational Neurobiology Group at the University of Oxford.

"We've reached two important conclusions. Firstly, COVID-19 markedly increases the risk of CVT, adding to the list of blood clotting problems this infection causes.

"Secondly, the COVID-19 risk is higher than we see with the current vaccines, even for those under 30; something that should be taken into account when considering the balances between risks and benefits for vaccination," he said.

The study authors, led by Professor Harrison and Dr Maxime Taquet from Oxford University's Department of Psychiatry and the NIHR Oxford Health Biomedical Research Centre, counted the number of CVT cases diagnosed in the two weeks following diagnosis of COVID-19, or after the first dose of a vaccine. They then compared these to calculated incidences of CVT following influenza, and the background level in the general population.

"The signals that COVID-19 is linked to CVT, as well as portal vein thrombosis - a clotting disorder of the liver - is clear, and one we should take note of," said Dr Maxime Taquet, also from the Translational Neurobiology Group.

In the study of over 500,000 COVID-19 patients, CVT occurred in 39 in a million patients. In over 480,000 people receiving a COVID-19 mRNA vaccine, such as Pfizer/BioNTech or Moderna, CVT occurred in four in a million, and CVT has been reported to occur in about five in a million people after first dose of the Oxford/AstraZeneca COVID-19 vaccine.

"Compared to the mRNA vaccines, the risk of a CVT from COVID-19 is about 10 times greater. Compared to the AZ-Oxford (Oxford/AstraZeneca) vaccine, the risk of a CVT from COVID-19 is about eight times greater," the findings note.

However, the researchers said that all comparisons must be interpreted cautiously since data is still accruing. An important factor that requires further research is whether COVID-19 and vaccines lead to CVT by the same or different mechanisms. There may also be under-reporting or mis-coding of CVT in medical records, and therefore uncertainty as to the precision of the results, the study authors note.

The findings come as numerous countries have limited use of the Oxford/AstraZeneca vaccine to certain age groups or paused its rollout. Denmark has dropped the jab from its vaccination programme permanently following reports of very rare cases of blood clots.

Earlier this month, the UK''s Medicines and Healthcare products Regulatory Agency (MHRA) said the vaccine is still safe and effective but said that people under-30 will be offered an alternative, where possible, as an additional precaution.

The overall advice, including from the World Health Organisation (WHO), remains in favour of continued vaccinations as the experts concluded that the life-saving benefits of the Oxford/AstraZeneca vaccine continue to outweigh the risks.
Newsletter

Related Articles

Arab Press
0:00
0:00
Close
China Criticizes US for Vetoing UN Ceasefire Resolution in Gaza
Saudi Arabia ranks first in UN index for e-government services in MENA
Israel Records 20% Drop In GDP, War In Gaza Is The Reason
Saudi Arabia's FDI Inflows Grow with New International Standards
Venture Capitals Power Up Across MENA Region
PM Modi Announces Opening Of New CBSE Office In Dubai
January Funding for MENA Startups Totals $86.5 Million
Saudi Arabia accelerates digital economy growth through Nvidia partnership
Israel unveils tunnels underneath Gaza City headquarters of UN agency for Palestinian refugees
Israel deploys new military AI in Gaza war
Egypt threatens to suspend key peace treaty if Israel pushes into Gaza border town, officials say
Saudi Arabia Warns Of A "Humanitarian Catastrophe" If Israel Moves On Rafah
US University To Shut Qatar Campus Due To "Heightened Mideast Instability"
Facebook and Instagram Ban Iran's Supreme Leader
Defense Technology Showcase Held in Riyadh
Saudi Arabia’s non-oil exports rise 2.5% to $6bn in November 2023: GASTAT
Rolls-Royce Executive Encourages Saudi Women to Tap into Their Inner 'Superhero' for Success in Defense Industry
Saudi Arabia launches National Academy of Vehicles and Cars
Saudi Tourism Minister Reveals Plan for 250,000 New Hotel Rooms by 2030
SAR to more than double eastern network passenger capacity with new trains deal
Saudi Arabia Enhances National Defense with New Partnerships
Saudi Aramco Maintains Arab Light Crude Pricing to Asia for March
NEOM Establishes New York Office to Support Investors
Saudi Wealth Fund Draws in Over $25 Billion Worth of Investments in Three Years, Al-Rumayyan Reveals
The Saudi Kingdom's Ultimatum to Israel: A Win-Win Peace with Saudi Arabia and the Arab World, or a Lose-Lose Continued Occupation and Endless Conflict
Biden condemns anti-Arab hate after WSJ opinion piece calls Dearborn ‘jihad capital’
Turkey Releases Seven Hostages Captured by Pro-Gaza Gunman
Arab Parliament Commends Women's Contributions to Societal Development
British and Hungarian Foreign Ministers visited Lebanese leaders to stress the importance of enacting UN Resolution 1701
Yemen's Houthis Say They Targeted British Merchant Vessel In Red Sea
Donald Trump Nominated for Nobel Peace Prize for 'Historic' Middle East Policy
US lawmakers approve F-16 jet sale to Turkey following NATO expansion support
Saudi Arabia Climbs 25 Places in World Bank's National Statistics Indicator
Tourism Growth in Saudi Arabia Fuels Advancements in the Hospitality Industry," Says Rotana Official
Houthi Rebels Request Departure of UN Staff from Yemen, Including US and UK Personnel, within a Month
Modi Inaugurates Hindu Temple on Site of Demolished Mosque in India
Over 25,000 Deaths in Gaza Amid Israeli Offensive
Escalating Clashes in Gaza as Israel Distributes Leaflets to Assist in Locating Hostages
Turkey's First Astronaut Set to Launch for International Space Station Today
Head of Palestinian Investment Fund Warns More People May Die of Hunger Than War in Gaza
Palestinian Envoy Criticizes UK for Alleged 'Double Standards' in Policies Toward Israel
Morocco to Lead UN Human Rights Council in 2024
Is artificial intelligence the solution to cyber security threats?
Egypt has been identified as the leading military force among Arab nations and ranks 15th globally
The AI Revolution in the Workforce: CEOs at Davos Predict Major Job Cuts in 2024
Iranian Nobel Laureate Narges Mohammadi Receives Additional Prison Sentence
"Gazans Urge Israeli Forces to Target Hamas in Leaked Audio"
Biden States US and UK Airstrikes on Houthis Were a 'Defensive Action
Large Pro-Palestine Rally in London as Gaza Conflict Hits Day 100
South Africa Urges World Court to Halt Israeli Actions in Gaza
×